Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Axlab, a Danish innovator within solutions for pathology laboratories, is expanding its presence in the US to meet the growing demand for fully automated sectioning workflows with the AS-410M. In the last decade, 100 AS-410M automated slide preparation systems have been successfully implemented, optimizing workflows and enhancing sectioning quality, thus ensuring a strong foothold worldwide.

“In order to ensure that we have all competencies, we have handpicked a team of highly skilled staff members with extensive experience in their respective fields, ensuring comprehensive coverage across the US. Since installing our first AS-410M device in Denmark in 2016, our Danish headquarters has gained vast expertise in automating pathology labs with diverse requirements and complex workflows. Combined with our US team, we are confident in achieving similar success in the US,” says Kris Rokke, National Sales Director for Axlab in the US. “My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow.”

The AS-410M received FDA clearance in 2024 and features high quality sectioning alongside full traceability, image capture, automatic blade replacement, patient data safety, and a controlled environment regardless of humidity and other factors, with quality as the core focus. Currently, at least 85% of AS-410M installations worldwide are used for clinical purposes.

It is possible to see the AS-410M on display at the National Society for Histotechnology (NSH) 2024 in New Orleans from September 20-24, 2024.

SourceAxlab

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version